Meconium Aspiration Syndrome, Hypoxic-Ischemic Encephalopathy and Therapeutic Hypothermia-A Recipe for Severe Pulmonary Hypertension?
Deepika SankaranJessa Rose A LiSatyan LakshminrusimhaPublished in: Children (Basel, Switzerland) (2024)
Hypoxic-ischemic encephalopathy (HIE) is the leading cause of mortality among term newborns globally. Infants born through meconium-stained amniotic fluid are at risk of developing meconium aspiration syndrome (MAS) and HIE. Simultaneous occurrence of MAS and HIE is a perilous combination for newborns due to the risk of persistent pulmonary hypertension of the newborn (PPHN). Moreover, therapeutic hypothermia (TH), which is the current standard of care for the management of HIE, may increase pulmonary vascular resistance (PVR) and worsen PPHN. Infants with MAS and HIE require close cardiorespiratory and hemodynamic monitoring for PPHN. Therapeutic strategies, including oxygen supplementation, ventilation, use of surfactant, inhaled nitric oxide and other pulmonary vasodilators, and systemic vasopressors, play a critical role in the management of PPHN in MAS, HIE, and TH. While TH reduces death or disability in infants with HIE, infants with MAS and HIE undergoing TH need close hemodynamic monitoring for PPHN.
Keyphrases
- pulmonary hypertension
- nitric oxide
- gestational age
- pulmonary artery
- early onset
- pulmonary arterial hypertension
- cardiac arrest
- pregnant women
- healthcare
- brain injury
- low birth weight
- multiple sclerosis
- risk assessment
- palliative care
- cystic fibrosis
- body composition
- type diabetes
- bone marrow
- coronary artery
- hydrogen peroxide
- cardiovascular events
- mechanical ventilation
- drug induced
- chronic pain
- high intensity
- health insurance